Disclosures for "Gabapentinoid Use Disorder in the Neuropathic Pain Unit Setting "
-
Dr. Evangelisti has nothing to disclose.
-
Dr. Falco has nothing to disclose.
-
Mr. De Stefano has nothing to disclose.
-
Daniel Litewczuk has nothing to disclose.
-
Eleonora Galosi has nothing to disclose.
-
Mr. Di Pietro has nothing to disclose.
-
Caterina Leone has nothing to disclose.
-
Andrea Truini has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viatris, Grunenthal, AbbVie, Amgen, Pharmaline. The institution of Andrea Truini has received research support from Angelini, Epitech, EU funded research projects.